Earth Science Tech Acquires Meduvo, Expanding Pharmacy Network to 34 U.S. Jurisdictions

Earth Science Tech's acquisition of Meduvo LLC establishes a West Coast hub and expands its pharmacy network to 34 states, positioning the company for nationwide sterile compounding capabilities by 2028.

SD Metrowire Staff
Healthcare
Earth Science Tech Acquires Meduvo, Expanding Pharmacy Network to 34 U.S. Jurisdictions

Earth Science Tech, Inc. (OTC: ETST) has announced the acquisition of Meduvo LLC, a compounding pharmacy based in La Verne, California. This strategic move establishes a West Coast operational hub and expands the company's pharmacy network to 34 U.S. jurisdictions, marking a significant step in its mission to build a vertically integrated healthcare platform.

The acquisition brings Meduvo's 2,000-square-foot facility, which currently compounds and dispenses non-sterile medications, under ETST's umbrella. The company has initiated upgrades to the facility to meet sterility requirements, with management targeting full regulatory certification for sterile compounding by the end of 2028. This timeline reflects the rigorous standards required for sterile compounding, a critical capability for expanding patient care services.

ETST's expansion strategy is not limited to California. The company noted that regulatory approvals are pending in additional states as it pursues nationwide coverage. This aggressive growth trajectory underscores the company's commitment to becoming a leader in the health and wellness sector.

The acquisition is a key component of ETST's broader operational strategy, which focuses on integrating compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. By leveraging synergies among its specialized subsidiaries, the company aims to seamlessly integrate patient care from consultation to fulfillment.

According to the company, the core of its value proposition lies in this integration, which enhances patient outcomes and operational efficiency. The addition of Meduvo not only expands ETST's geographic footprint but also strengthens its capacity to serve a growing patient base across the country.

Investors and industry observers will be watching closely as ETST navigates the regulatory landscape and works toward its 2028 certification goal. The company's ability to achieve sterile compounding capabilities will likely be a significant factor in its long-term growth and market positioning.

For more information on Earth Science Tech, Inc., visit the company's newsroom at https://ibn.fm/ETST.

Blockchain Registration

QR Code for Blockchain Registration